As HPV-vaccinated cohorts age into screening eligibility, researchers evaluated how cervical cancer screening intensity could be tailored by age at vaccination and vaccine type to balance benefits, harms,...
A recent study assessed cervical cancer mortality trends among US women younger than 25 from 1992 to 2021, highlighting changes in mortality rates following the widespread use of the HPV vaccine.
Researchers conducted an international, multicenter, randomized noninferiority trial comparing radical hysterectomy with simple hysterectomy, including lymph-node assessment, in patients with low-risk...
The Clinical Guidelines Committee of the American College of Physicians has published new best practice advice for screening average-risk women for cervical cancer.
Physicians reviewing patient-facing screening guidance from major cancer centers may encounter recommendations that do not fully align with USPSTF standards. In a cross-sectional analysis, investigators...
The available HPV vaccines could prevent most cases of cervical intraepithelial neoplasia and adenocarcinoma in situ, according to an HPV genotype study.
The US introduction of a vaccine to prevent cervical cancer in 2006 has reduced infections of HPV by more than half among girls and young women, US health officials said on Wednesday.
